Project Grant HT94252510428
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$1.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Monkton, MD 21111, USA
Similar Awards
This federal Project Grant award for $802,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award will fund preclinical gene therapy studies in a mouse model of TSC2 at Baylor College of Medicine in Houston, TX over the period of May 1, 2025 to April 30, 2028. The research aims to transform healthcare for military service members and the broader public by exploring innovative approaches to disease prevention,...
The federal Project Grant award of $6,663,794.00, awarded on September 30, 2024 by the Defense Health Agency, supports the "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY" research initiative under the Military Medical Research and Development (CFDA 12.420) program. This grant will fund advanced biomedical research focused on transforming healthcare for military service members, with a particular emphasis on conditions relevant to military personnel and...
This federal Project Grant award of $783,023, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a precision-medicine approach to targeting acquired therapeutic resistance in RTK-mutated non-small cell lung cancer (NSCLC). The grant is awarded to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a global nonprofit organization dedicated to supporting military medical research, education, and...
This federal Project Grant award, valued at $1,030,660.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will conduct scientific investigations spanning basic, applied, and...
The U.S. Department of the Army Medical Command awarded a $5,599,141 Project Grant to Kuda Therapeutics, Inc., a woman-owned small business located in Salt Lake City, Utah. The grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports the advancement of a novel, orally available ferroptosis inducer for the treatment of Von Hippel-Lindau (VHL) disease. The award period runs from June 1, 2025, to May 31, 2028. The Military Medical Research and...
The Department of the Army Medical Command awarded a $1,644,309 Project Grant (CFDA 12.420 - Military Medical Research and Development) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research focused on "FUNCTIONAL MOLECULAR NETWORKS MODIFYING HIF2A ACTIVITY IN VHL TUMORS." The funding will support advanced biomedical research initiatives over a 36-month period from February 1, 2025 to January 31, 2028. As a major recipient of...
This $317,001 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) will support the University of Texas at Austin's investigation of clot mechanics in pulmonary failure and thromboembolic disease in sickle cell anemia. The research aims to improve understanding and treatment of these conditions, which are of high relevance to military medicine. The 2-year project will leverage the university's...
The Department of the Army Medical Command, through its Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $1,999,583 project grant to IRR Inc. located in Santa Barbara, CA. The funding supports an early-stage proof-of-concept study of a fixed-dose combination therapy in a high-fidelity porcine model of severe polytrauma. The 2-year project, running from July 1, 2025 to June 30, 2027, aims to explore innovative approaches to disease prevention, diagnosis,...
This $2.29 million Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research into the "Regulation of ALK1 Signaling in the Endothelium" from September 1, 2021 through August 31, 2025. The University of Pittsburgh will conduct the research as the primary awardee. A $200,000 subaward to the University of Massachusetts Medical School will support related research activities. Through this funding, the...
The federal Project Grant award in the amount of $2,402,721.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a patient monitoring and decision-support platform for precision health initiatives. The award was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization that specializes in providing medical research, education, and...